CHRISTINE HANNA: Open Payments
NPI 1639470370 · JACKSONVILLE, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$552 in 31 payments from 12 companies in 2025. Trend: 2023 $398 · 2024 $6,235 · 2025 $552
Food & beverage: $518Education: $34
| Company | Payments | Amount |
|---|---|---|
| Novartis Pharmaceuticals Corporation | 13 | $179 |
| Regeneron Healthcare Solutions, Inc. | 4 | $72 |
| GlaxoSmithKline, LLC. | 3 | $51 |
| CSL Behring | 2 | $45 |
| Pharming Healthcare, Inc. | 2 | $42 |
| Amgen Inc. | 1 | $34 |
| Greer Laboratories, Inc. | 1 | $29 |
| Optinose US, Inc. | 1 | $25 |
| AstraZeneca Pharmaceuticals LP | 1 | $25 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $18 |
Products named: DUPIXENT, RUCONEST, TRELEGY ELLIPTA, ORALAIR, Rhapsido, Xhance, FASENRA, Haegarda.
Industry payments across FL — which companies pay providers there.
